[1] Angell JE,Lindner DJ,Shapiro PS,et al.Identification of GRIM-19,a novel cell death-regulatory gene induced by the interferon-beta and retinoic acid combination，using agenetic approach［J］.J Biol Chem,2000,275(43):33416-33426.
[2] Donatini G,Beaulieu A,Castagnet M,et al.Thyroid Hürthle cell tumors:Research of potential markers of malignancy［J］.J Endocrinol Invest,2016,39(2):153-158.
[3] Fan XY,Jiang ZF,Cai L,et al．Expression and clinical significance of GRIM-19 in lung cancer［J］.Med Oncol,2012,29(5):3183-3189．
[4] Li F,Ren W,Zhao Y,et al．Down regulation of GRIM-19 is associated with hyperactivation of p-STAT3 in hepatocellular carcinoma［J］.Med Oncol,2012,29(5):3046-3054.
[5] Nallar SC,Kalvakolanu DV.GRIM-19:A master regulator of cytokine induced tumor suppression,metastasis and energy metabolism［J］.Cytokine Growth Factor Rev，2017,33:1-18.
[6] Kapoor S.Grim-19 expression and its close association with tumor progression in systemic malignancies［J］.Gene,2013,517(2):240.
[7] Xu X,Zhu Y.Curcumin inhibits human non-small cell lung cancer xenografts by targeting STAT3 pathway［J］.Am J Transl Res,2017,9(8):3633-3641.
[8] Ma DH,Li BS,Liu JJ,et al.miR-93-5p/IFNAR1 axis promotes gastric cancer metastasis through activating the STAT3 signaling pathway［J］.Cancer Lett,2017,24(408):23-32.
[9] Qiao L,Li XJ,Yang ZY,et al.Expression of STAT3 and p-STAT3 in human squamous carcinoma cells and its relationship with clinicopathological characteristics［J］.J Shanxi Med Univ,2015,46(12):1207-1210.［乔丽，李新技，杨志勇，等.STAT3及p-STAT3在皮肤鳞状细胞癌中的表达及其与鳞癌临床病理特征的关系［J］.山西医科大学学报，2015,46(12):1207-1210.］
[10] Ren M,Wang Y,Wu X,et al.Curcumin synergistically increases effects of β-interferon and retinoic acid on breast cancer cells in vitro and in vivo by up-regulation of GRIM-19 through STAT3-dependent and STAT3-independent pathways［J］.J Drug Target,2017,25(3):247-254.
[11] Zhao J,Nie W,Li W,et al.Interferon-β combined with all-trans retinoic acid supresses proliferation and promote apoptosis by inhibiting JAK2/STAT3 pathway in HepG2 human hepatocellular carcinoma cells［J］.Chinese J Cellular and Molecular Immunology,2016,32(7):901-905.
[12] Huang Y,Yang M,Hu H,et al.Mitochondrial GRIM-19 as a potential therapeutic target for STAT3-dependent carcinogenesis of gastric cancer［J］.Oncotarget,2016,7(27):41404-41420.
[13]Zhang XY,Li M,Sun K，et al.Decreased expression of GRIM-19 by DNA hypermethylation promotes aerobic glycolysis and cell proliferation in head and neck squamous cell carcinoma［J］.Oncotarget，2015，6(1)：101-115.
[14]Zhang X，Choe MS，Lee JE，et al．GRIM-19 expression and its correlation with clinical outcomes of an induction chemotherapy for patients with locally advanced squamous cell carcinoma of the head and neck(SCCHN)［J］.J Clin Oncol，2005，23（16）：5519-5523．
[15]Kalakonda S,Nallar SC,Jaber S,et al.Monoallelic loss of tumor suppressor GRIM-19 promotes tumorigenesis in mice［J］.Proc Natl Acad Sci USA，2013，110(45)：E4213- E4222.